{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T10:26:21Z","timestamp":1781519181689,"version":"3.54.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,6]]},"DOI":"10.7759\/cureus.18523","type":"journal-article","created":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T11:00:11Z","timestamp":1633518011000},"source":"Crossref","is-referenced-by-count":2,"title":["Breast Apocrine Carcinoma Detected Incidentally as Axillary Lymphadenopathy in a CT Scan"],"prefix":"10.7759","author":[{"given":"Marina","family":"Barron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira","family":"Asaad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Idaewor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noreen","family":"Rasheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdalla","family":"Saad Abdalla Al-Zawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"The Oncotype DX recurrence score impact on the management of ER-positive, HER2-negative, node-negative breast cancer","volume":"6","author":"Al-Zawi AS","year":"2021","unstructured":"Al-Zawi AS. The Oncotype DX recurrence score impact on the management of ER-positive, HER2-negative, node-negative breast cancer. Med Res J. 2021, 6:211-6.","journal-title":"Med Res J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000671","article-title":"Pure apocrine carcinomas represent a clinicopathologically distinct androgen receptor-positive subset of triple-negative breast cancers","volume":"40","author":"Mills AM","year":"2016","unstructured":"Mills AM, E Gottlieb C, M Wendroth S, M Brenin C, Atkins KA. Pure apocrine carcinomas represent a clinicopathologically distinct androgen receptor-positive subset of triple-negative breast cancers. Am J Surg Pathol. 2016, 40:1109-16. 10.1097\/PAS.0000000000000671","journal-title":"Am J Surg Pathol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/jscr\/rju045","article-title":"A rare presentation of triple-negative apocrine breast carcinoma with metastases","volume":"2014","author":"Bedford T","year":"2014","unstructured":"Bedford T, Alperstein A, Nathani Y, Marx R, DeVito P. A rare presentation of triple-negative apocrine breast carcinoma with metastases. J Surg Case Rep. 2014, 2014:rju045. 10.1093\/jscr\/rju045","journal-title":"J Surg Case Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.2014.19.294.2973","article-title":"Apocrine carcinoma of the male breast: a case report of an exceptional tumor","volume":"19","author":"Sekal M","year":"2014","unstructured":"Sekal M, Znati K, Harmouch T, Riffi AA. Apocrine carcinoma of the male breast: a case report of an exceptional tumor. Pan Afr Med J. 2014, 19:294. 10.11604\/pamj.2014.19.294.2973","journal-title":"Pan Afr Med J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2018-205485","article-title":"Apocrine lesions of the breast: part 2 of a two-part review. Invasive apocrine carcinoma, the molecular apocrine signature and utility of immunohistochemistry in the diagnosis of apocrine lesions of the breast","volume":"72","author":"D'Arcy C","year":"2019","unstructured":"D'Arcy C, Quinn CM. Apocrine lesions of the breast: part 2 of a two-part review. Invasive apocrine carcinoma, the molecular apocrine signature and utility of immunohistochemistry in the diagnosis of apocrine lesions of the breast. J Clin Pathol. 2019, 72:7-11. 10.1136\/jclinpath-2018-205485","journal-title":"J Clin Pathol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.17305\/bjbms.2016.1811","article-title":"Apocrine carcinoma of the breast: a brief update on the molecular features and targetable biomarkers","volume":"17","author":"Vranic S","year":"2017","unstructured":"Vranic S, Feldman R, Gatalica Z. Apocrine carcinoma of the breast: a brief update on the molecular features and targetable biomarkers. Bosn J Basic Med Sci. 2017, 17:9-11. 10.17305\/bjbms.2016.1811","journal-title":"Bosn J Basic Med Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp245","article-title":"Breast carcinoma\u2014rare types: review of the literature","volume":"20","author":"Yerushalmi R","year":"2009","unstructured":"Yerushalmi R, Hayes MM, Gelmon KA. Breast carcinoma\u2014rare types: review of the literature. Ann Oncol. 2009, 20:1763-70. 10.1093\/annonc\/mdp245","journal-title":"Ann Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.21614\/chirurgia.115.4.511","article-title":"Breast adenoid cystic carcinoma in a patient with previous contra-lateral breast ductal carcinoma in-situ: a case report","volume":"115","author":"Barron M","year":"2020","unstructured":"Barron M, Asaad A, Khan KA, et al.. Breast adenoid cystic carcinoma in a patient with previous contra-lateral breast ductal carcinoma in-situ: a case report. Chirurgia (Bucur). 2020, 115:511-9. 10.21614\/chirurgia.115.4.511","journal-title":"Chirurgia (Bucur)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.14445\/23939117\/IJMS-V7I11P101","article-title":"Ki67 proliferative index as a predictive tool for axillary pathological complete response in node-positive breast cancer","volume":"7","author":"Al-Zawi AS","year":"2020","unstructured":"Al-Zawi AS. Ki67 proliferative index as a predictive tool for axillary pathological complete response in node-positive breast cancer. Int J Med Sci. 2020, 7:1-4. 10.14445\/23939117\/IJMS-V7I11P101","journal-title":"Int J Med Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/his.14091","article-title":"The 2019 World Health Organization classification of tumours of the breast","volume":"77","author":"Tan PH","year":"2020","unstructured":"Tan PH, Ellis I, Allison K, et al.. The 2019 World Health Organization classification of tumours of the breast. Histopathology. 2020, 77:181-5. 10.1111\/his.14091","journal-title":"Histopathology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1177\/0300891620914132","article-title":"Apocrine carcinoma of breast in a male patient: case report","volume":"106","author":"Touimi SH","year":"2020","unstructured":"Touimi SH, N\u2019chiepo D, Mbarki I, et al.. Apocrine carcinoma of breast in a male patient: case report. Tumori. 2020, 106:12-3. 10.1177\/0300891620914132","journal-title":"Tumori"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2007.02888.x","article-title":"An update on apocrine lesions of the breast","volume":"52","author":"O'Malley FP","year":"2008","unstructured":"O'Malley FP, Bane A. An update on apocrine lesions of the breast. Histopathology. 2008, 52:3-10. 10.1111\/j.1365-2559.2007.02888.x","journal-title":"Histopathology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2010.50","article-title":"EGFR and HER-2\/neu expression in invasive apocrine carcinoma of the breast","volume":"23","author":"Vranic S","year":"2010","unstructured":"Vranic S, Tawfik O, Palazzo J, et al.. EGFR and HER-2\/neu expression in invasive apocrine carcinoma of the breast. Mod Pathol. 2010, 23:644-53. 10.1038\/modpathol.2010.50","journal-title":"Mod Pathol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.36959\/739\/516","article-title":"Apocrine carcinoma of the male breast: a case report","volume":"1","author":"Yee C","year":"2017","unstructured":"Yee C, Wan B, Drost L, et al.. Apocrine carcinoma of the male breast: a case report. Ann Breast Cancer. 2017, 1:3. 10.36959\/739\/516","journal-title":"Ann Breast Cancer"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199505000-00007","article-title":"Myoblastomatoid (histiocytoid) carcinoma of the breast. A type of apocrine carcinoma","volume":"19","author":"Eusebi V","year":"1995","unstructured":"Eusebi V, Foschini MP, Bussolati G, Rosen PP. Myoblastomatoid (histiocytoid) carcinoma of the breast. A type of apocrine carcinoma. Am J Surg Pathol. 1995, 19:553-62. 10.1097\/00000478-199505000-00007","journal-title":"Am J Surg Pathol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2004.019794","article-title":"Axillary apocrine carcinoma with benign apocrine tumours: a case report involving a pathological and immunohistochemical study and review of the literature","volume":"58","author":"Miyamoto T","year":"2005","unstructured":"Miyamoto T, Hagari Y, Inoue S, Watanabe T, Yoshino T. Axillary apocrine carcinoma with benign apocrine tumours: a case report involving a pathological and immunohistochemical study and review of the literature. J Clin Pathol. 2005, 58:757-61. 10.1136\/jcp.2004.019794","journal-title":"J Clin Pathol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2018.06.005","article-title":"Androgen receptor in triple negative breast cancer: a potential target for the targetless subtype","volume":"68","author":"Gerratana L","year":"2018","unstructured":"Gerratana L, Basile D, Buono G, et al.. Androgen receptor in triple negative breast cancer: a potential target for the targetless subtype. Cancer Treat Rev. 2018, 68:102-10. 10.1016\/j.ctrv.2018.06.005","journal-title":"Cancer Treat Rev"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq678","article-title":"Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers","volume":"22","author":"Park S","year":"2011","unstructured":"Park S, Koo JS, Kim MS, et al.. Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers. Ann Oncol. 2011, 22:1755-62. 10.1093\/annonc\/mdq678","journal-title":"Ann Oncol"},{"key":"ref19","article-title":"The apocrine carcinoma of the breast. A cytological, immunohistochemical and ultrastructural study of 6 cases","volume":"140","author":"Alexiev B","year":"1994","unstructured":"Alexiev B, Boschnakova Z, Prokopanov C. The apocrine carcinoma of the breast. A cytological, immunohistochemical and ultrastructural study of 6 cases. Zentralbl Pathol. 1994, 140:129-34.","journal-title":"Zentralbl Pathol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.clbc.2012.11.004","article-title":"Immunohistochemically defined subtypes and outcome of apocrine breast cancer","volume":"13","author":"Dellapasqua S","year":"2013","unstructured":"Dellapasqua S, Maisonneuve P, Viale G, et al.. Immunohistochemically defined subtypes and outcome of apocrine breast cancer. Clin Breast Cancer. 2013, 13:95-102. 10.1016\/j.clbc.2012.11.004","journal-title":"Clin Breast Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/71878-breast-apocrine-carcinoma-detected-incidentally-as-axillary-lymphadenopathy-in-a-ct-scan","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:31:20Z","timestamp":1707507080000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/71878-breast-apocrine-carcinoma-detected-incidentally-as-axillary-lymphadenopathy-in-a-ct-scan"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,6]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.18523","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,6]]}}}